Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention (2019)
J Diabetes Sci Technol 4:13221331 Gelling RW, Du XQ, Dichmann DS et al (2003) Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice
"For many of these added ingredients, we simply don't have good evidence showing they improve safety or effectiveness." Additionally, among the 23 compounding pharmacies supplying these businesses, four lacked licenses for sterile compounding, while several had recent disciplinary actions or FDA warning letters related to sterile compounding practices
Reid A et al
It belongs to a class of drugs called GLP-1 receptor agonists (glucagon-like peptide-1 mimetics)
D12492i) male C57BL/6 mice (6 months old) were randomized based on body weight and received pre-treatment of IgG1, GIPR-Ab (5 mg kg 1 ) or GIPR-Ab/GLP-1 (1.5 mg kg 1 ), dosed 24 h before an assay treatment of vehicle or [D-Ala 2 ]-GIP (100 nmol kg 1 , human